文献速递冠心病外科

β受体阻滞剂与冠状动脉旁路移植术后结局的关联:1年前后对比

Association Between β-Blockers and Outcome of Coronary Artery Bypass Grafting: Before and After 1 Year.
PubMed 文献 · Ann Thorac Surg · 2020-06-18

该研究基于2001至2014年5382例CABG患者,按出院时是否使用β受体阻滞剂分组,采用倾向评分匹配和landmark分析评估长期结局。结果显示β受体阻滞剂与48个月随访全因死亡风险降低相关(HR 0.62),但landmark分析提示获益主要限于术后前12个月(HR 0.37),12个月后无显著获益(HR 0.92)。

要点

  • 出院时β受体阻滞剂与48个月全因死亡风险降低相关(HR 0.62)。
  • 获益主要集中于术后前12个月(HR 0.37),12个月后不显著。
  • β受体阻滞剂术后长期使用的最佳疗程尚不明确。

核心结论

  • 出院后β受体阻滞剂的获益可能仅限于CABG术后1年内,需进一步研究确认。

研究设计与样本

  • 回顾性队列研究,纳入2001年1月至2014年12月5382例CABG患者。
  • 按出院时β受体阻滞剂治疗分为β受体阻滞剂组3677例(68.3%)和无β受体阻滞剂组1705例(31.7%)。
  • 采用倾向评分匹配分析和landmark分析评估48个月随访全因死亡。

临床怎么用

  • CABG术后出院时考虑使用β受体阻滞剂以降低近期全因死亡风险。
  • 术后1年后β受体阻滞剂的长期获益不明确,需个体化评估。

局限性

  • 原文未报告具体局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We evaluated the long-term outcomes of coronary artery bypass grafting (CABG) according to β-blocker therapy using landmark analysis. Although β-blockers have been shown to improve outcomes for ischemic heart disease, the long-term effects and optimal treatment duration of use after CABG remain unknown. METHODS: From January 2001 to December 2014, 5382 CABG patients were stratified into 2 groups according to β-blocker therapy at discharge (β-blocker group: 3677 [68.3%], no β-blocker group: 1705 [31.7%]). RESULTS: The primary outcome was all-cause death during 48 months of follow-up. Using propensity score-matched analysis, β-blocker therapy was associated with all-cause death during the 48-month follow-up (hazard ratio [HR], 0.62; 95% confidence interval [CI], 0.41-0.95; P = .03). The landmark analysis demonstrated that the effect of β-blockers on all-cause death was particularly significant within the first 12 months of therapy (HR, 0.37; 95% CI, 0.19-0.80; P = .01) but not after 12 months (HR, 0.92; 95% CI, 0.56-1.53; P = .77). CONCLUSIONS: The benefits of postdischarge β-blockers may be limited to 1 year after CABG, but further studies are required to confirm this finding.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Park J, Lee SH, Jeong DS, et al. Association Between β-Blockers and Outcome of Coronary Artery Bypass Grafting: Before and After 1 Year. Ann Thorac Surg. 2020. PMID: 32565089. doi:10.1016/j.athoracsur.2020.04.127

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。